
In this solo episode of the Tell-Tale Heart podcast, host Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP, delivers an immediate reaction to the newly released 2026 AHA/ACC/ADA/ASN guidelines for cardiovascular kidney metabolic (CKM) syndrome. Beavers calls the document a landmark framework that formally unites obesity, diabetes, chronic kidney disease, heart failure, and atherosclerotic cardiovascular disease into a single disease continuum — a shift he argues changes everything about how clinicians should approach prevention.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

S2 Ep93: Insights from ESC: Treat Earlier, Implement Better, and Question What We Thought We Knew

S1 Ep37: ESC 2026 Hot Line Recap: 3 Trials Every Pharmacist Needs

36: 2026 ACC Consensus Pathway Redefines HFpEF Diagnosis, Treatment Priorities

35: Deprescribing in Cardiovascular Disease: A New AHA Roadmap for Tackling Polypharmacy
Free AI-powered recaps of The Tell-Tale Heart: The Pharmacist's Cardiovascular Digest and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.